OncoStem

OncoStem develops innovative prognostic tests that assess the aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. OncoStem’s vision is to empower doctors with evidence-based treatment plans with their smart prognostic tests. These actionable tests help physicians formulate a customized treatment plan by understanding tumour biology.

61.3
61.3
NaN
NaN
NaN
NaN
Links
Valuation
$
Funding
$ 6.00 M
$ 9.00 M
Statistics
NA

OncoStem develops innovative prognostic tests that assess the aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. OncoStem’s vision is to empower doctors with evidence-based treatment plans with their smart prognostic tests. These actionable tests help physicians formulate a customized treatment plan by understanding tumour biology.

Overview
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
0and0